New research finds brisk walking may lower your risk of developing type 2 diabetes. In the study, people who walked at a faster-than-normal pace were nearly 40% less likely to develop the condition.

Dyne Therapeutics announces FDA Fast Track designation for DYNE-101, targeting myotonic dystrophy type 1 with potential accelerated approval in 2026. Dyne Therapeutics has announced that its ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted a second fast-track designation for a type 1 diabetes immunotherapy. The FDA will allow ...

For people with near-total paralysis, the ability to communicate easily in real time is a challenge. For years, scientists have been working to remedy that by developing devices that can decode brain ...

Honda has once again proven that they can take an already impressive car and turn it into something extraordinary. The 2023 Honda Civic Type R arrived in our drive, and after a week behind the wheel ...

Chase Bierenkoven is a gearhead and writer based in Denver, Colorado. As the family lore goes, Chase's first word was "truck." Cars have been a problem ever since. By 16, Chase was spending his ...